Mô tả
Western blot or gene expression data from the liraglutide-Myo1c/Dock5 study quantify changes in key signaling proteins associated with diabetic wound repair. Downstream effectors of the GLP-1 pathway are activated in treated wound tissue.
Figure 5
ChartSource Paper
Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
PMID: 39159301
Cite This Figure
![Figure 5: Western blot or gene expression data from the liraglutide-Myo1c/Dock5 study quantify changes in key signaling proteins associated with diabetic wound repair. Downstream effectors of the GLP-1 pathway are activated in treated wound tissue.]() > Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." *Advanced science (Weinheim, Baden-Wurttemberg, Germany)*, 2024. PMID: [39159301](https://pubmed.ncbi.nlm.nih.gov/39159301/)
<figure> <img src="" alt="Western blot or gene expression data from the liraglutide-Myo1c/Dock5 study quantify changes in key signaling proteins associated with diabetic wound repair. Downstream effectors of the GLP-1 pathway are activated in treated wound tissue." /> <figcaption>Figure 5. Western blot or gene expression data from the liraglutide-Myo1c/Dock5 study quantify changes in key signaling proteins associated with diabetic wound repair. Downstream effectors of the GLP-1 pathway are activated in treated wound tissue.<br> Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." <em>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39159301/">39159301</a></figcaption> </figure>